Janux Therapeutics (JANX) News Today $32.88 +0.83 (+2.59%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$30.63 -2.25 (-6.84%) As of 09:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential?May 5 at 8:07 AM | insidermonkey.comJanux Therapeutics (JANX) Expected to Announce Earnings on TuesdayMay 5 at 2:47 AM | americanbankingnews.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by Ally Bridge Group NY LLCAlly Bridge Group NY LLC reduced its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 17.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 90,292 shares of the company's stock after selling 1May 4 at 7:45 AM | marketbeat.comSchonfeld Strategic Advisors LLC Sells 39,855 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Schonfeld Strategic Advisors LLC decreased its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 26.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 109,500 shares of the company's stock after selling 39,85May 4 at 5:16 AM | marketbeat.comRA Capital Management L.P. Acquires 1,200,000 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)RA Capital Management L.P. boosted its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 13.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,365,652 shares of the company'May 3 at 7:48 AM | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Insider Sells $106,755.99 in StockMay 3 at 5:29 AM | insidertrades.comSamsara BioCapital LLC Trims Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)Samsara BioCapital LLC cut its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 50.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,263 shares of the company's stock afMay 2 at 7:24 AM | marketbeat.comFirst Trust Advisors LP Makes New $6.86 Million Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)First Trust Advisors LP acquired a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 128,062 shares of theMay 2 at 4:05 AM | marketbeat.comMarshall Wace LLP Sells 25,703 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Marshall Wace LLP trimmed its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 53.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,348 shares of the company's stock after selling 25,7May 2 at 3:52 AM | marketbeat.comJanux Therapeutics (JANX) to Release Quarterly Earnings on TuesdayJanux Therapeutics (NASDAQ:JANX) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-janux-therapeutics-inc-stock/)May 1, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Increases Position in Janux Therapeutics, Inc. (NASDAQ:JANX)Price T Rowe Associates Inc. MD grew its stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 596.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,109,978 shares of the company's stock after acquiring anMay 1, 2025 | marketbeat.com12,200 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Acquired by Teachers Retirement System of The State of KentuckyTeachers Retirement System of The State of Kentucky acquired a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 12,200 shares ofMay 1, 2025 | marketbeat.comFirst Light Asset Management LLC Invests $16.80 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)First Light Asset Management LLC purchased a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 313,782 shares of the company'sApril 30, 2025 | marketbeat.comArtia Global Partners LP Buys New Shares in Janux Therapeutics, Inc. (NASDAQ:JANX)Artia Global Partners LP purchased a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 162,976 shares of the company's stock, valued at approximately $8,726,00April 29, 2025 | marketbeat.comTri Locum Partners LP Takes Position in Janux Therapeutics, Inc. (NASDAQ:JANX)Tri Locum Partners LP acquired a new position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 236,407 shares of the companyApril 29, 2025 | marketbeat.comGilder Gagnon Howe & Co. LLC Acquires 41,030 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Gilder Gagnon Howe & Co. LLC raised its stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 361.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 52,379 shares of the company's stock after purcApril 29, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Position Increased by Lord Abbett & CO. LLCLord Abbett & CO. LLC grew its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 80.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,267,803 shares of the company's stock after purchasing an additional 564,322 sharApril 28, 2025 | marketbeat.comLegal & General Group Plc Has $1.85 Million Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)Legal & General Group Plc lifted its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 45.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,540 shares of the company's stock after buyiApril 28, 2025 | marketbeat.comLPL Financial LLC Makes New $439,000 Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)LPL Financial LLC bought a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 8,202 shares of the company's stock, valued at approximately $439,000. Other institutApril 28, 2025 | marketbeat.comBrokerages Set Janux Therapeutics, Inc. (NASDAQ:JANX) Target Price at $95.25April 28, 2025 | americanbankingnews.comJanux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Rating of "Buy" from AnalystsShares of Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) have been assigned a consensus rating of "Buy" from the eleven research firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, eight have assignedApril 27, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Buys 986,750 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Adage Capital Partners GP L.L.C. grew its stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 47.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,061,750 shares of the company's stock after purchApril 25, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Insider Andrew Hollman Meyer Sells 3,334 SharesApril 24, 2025 | insidertrades.comRock Springs Capital Management LP Invests $10.95 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)Rock Springs Capital Management LP purchased a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 204,466 shares of the company's stock, valued at approximately $10,947,000. RoApril 23, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Barclays PLCBarclays PLC boosted its position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 51.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 263,970 shares of the company's stock after buyiApril 22, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Invesco Ltd.Invesco Ltd. boosted its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 2,764.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 284,662 shares of the company's stock after acquiring an additApril 22, 2025 | marketbeat.comEAM Investors LLC Invests $2.84 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)EAM Investors LLC purchased a new position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 53,026 shares of the company's stock, valued at approximately $2April 19, 2025 | marketbeat.comGeode Capital Management LLC Boosts Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX)Geode Capital Management LLC increased its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 7.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 714,956 shares of the company's stock afterApril 17, 2025 | marketbeat.comJPMorgan Chase & Co. Boosts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX)JPMorgan Chase & Co. boosted its stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 941.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 191,603 shares of the company's stock after acquiring an additional 173,211 shares durApril 16, 2025 | marketbeat.comQuinn Opportunity Partners LLC Makes New Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)Quinn Opportunity Partners LLC purchased a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 20,000 shares of the company's stock, valued at approximately $1,071,000. A number of otherApril 14, 2025 | marketbeat.comFmr LLC Acquires 845,266 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Fmr LLC increased its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 10.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,669,941 shares of the company's stock afterApril 12, 2025 | marketbeat.com9,378 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Acquired by Sei Investments Co.Sei Investments Co. bought a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 9,378 shares of the company's stockApril 12, 2025 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Reaches New 1-Year Low - Time to Sell?Janux Therapeutics (NASDAQ:JANX) Reaches New 12-Month Low - What's Next?April 11, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. boosted its position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 15.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,136,332 shares of the company's stock afterApril 10, 2025 | marketbeat.comADAR1 Capital Management LLC Acquires 18,509 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)ADAR1 Capital Management LLC grew its holdings in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 142.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 31,509 shares of the company's stock after purchasiApril 9, 2025 | marketbeat.comWellington Management Group LLP Acquires 520,898 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Wellington Management Group LLP raised its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 3,592.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 535,396 shares of the company'sApril 9, 2025 | marketbeat.comSpringhill Fund Asset Management HK Co Ltd Invests $1.59 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)Springhill Fund Asset Management HK Co Ltd purchased a new position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 29,600 shares of the companApril 8, 2025 | marketbeat.comTrexquant Investment LP Buys New Shares in Janux Therapeutics, Inc. (NASDAQ:JANX)Trexquant Investment LP purchased a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 65,858 shares of the cApril 8, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Bought by Franklin Resources Inc.Franklin Resources Inc. grew its stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 2,519.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 497,287 shares of the company's stock after purchasing an addiApril 8, 2025 | marketbeat.comJanux Therapeutics: What's My Inflection Point?April 7, 2025 | seekingalpha.comJanux Therapeutics: What's My Inflection Point?April 7, 2025 | seekingalpha.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Rhenman & Partners Asset Management ABRhenman & Partners Asset Management AB raised its holdings in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 59.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 170,000 shares of the company's stock after acquiring an additionalApril 7, 2025 | marketbeat.comPamalican Asset Management Ltd Makes New Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)Pamalican Asset Management Ltd purchased a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 25,000 shares of the company's stock, valued at approximately $1,338,000. Several otherApril 6, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Schroder Investment Management GroupSchroder Investment Management Group boosted its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 111.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 156,874 shares of the company's stock after aApril 6, 2025 | marketbeat.comJanux Therapeutics: Buying For The Promising Pipeline, Holding For The BuyoutApril 5, 2025 | seekingalpha.comJanux Therapeutics (NASDAQ:JANX) Trading Up 7.5% - Still a Buy?Janux Therapeutics (NASDAQ:JANX) Trading Up 7.5% - Time to Buy?April 4, 2025 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Reaches New 12-Month Low - Should You Sell?Janux Therapeutics (NASDAQ:JANX) Reaches New 12-Month Low - Here's What HappenedApril 4, 2025 | marketbeat.comPictet Asset Management Holding SA Purchases New Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)Pictet Asset Management Holding SA acquired a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 384,797 shaApril 2, 2025 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Shares Down 7.1% - What's Next?Janux Therapeutics (NASDAQ:JANX) Shares Down 7.1% - Here's WhyApril 1, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Recommendation of "Buy" from AnalystsJanux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) has been given a consensus rating of "Buy" by the twelve research firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assMarch 31, 2025 | marketbeat.com Get Janux Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter. Email Address JANX Media Mentions By Week JANX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JANX News Sentiment▼1.330.73▲Average Medical News Sentiment JANX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JANX Articles This Week▼185▲JANX Articles Average Week Get Janux Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LNTH News Today BBIO News Today TGTX News Today LEGN News Today SRPT News Today TLX News Today ADMA News Today BPMC News Today VRNA News Today NUVL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JANX) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Janux Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Janux Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy JANX Stock Free JANX Stock Alerts